Neo Jialing’s Journey from Clinical Trial Recruitment to ASCO Recognition – NCCS
Neo Jialing/LinkedIn

Neo Jialing’s Journey from Clinical Trial Recruitment to ASCO Recognition – NCCS

National Cancer Centre Singapore (NCCS) shared on LinkedIn:

“Earlier this year, clinical research coordinator Neo Jialing found herself at the world’s largest oncology conference, answering questions from hundreds of people about her study on nasopharyngeal cancer (NPC) treatment!

At that same ASCO Annual Meeting 2026, she received the prestigious Conquer Cancer Merit Award. It’s a milestone she could never have imagined when she first started working at NCCS, recruiting patients for clinical trials.

Find out how Jialing’s journey led her to become an award-winning researcher.

And learn more about working at NCCS in Issue 18 of the In Good Health newsletter.”

About NCCS

The National Cancer Centre Singapore (NCCS) is one of Singapore’s leading cancer institutions, specialising in cancer treatment, patient care, research and education. Established in 1999 and officially opened in 2000, it operates under SingHealth and plays an important role in the country’s public healthcare system.

The centre brings together specialists from different fields, including medical, surgical and radiation oncology, as well as palliative care and rehabilitation, to provide comprehensive cancer care. It also offers advanced treatment options such as proton therapy, immunotherapy and cell therapy.

Alongside patient care, NCCS is actively involved in cancer research, working with local and international partners to improve the understanding, diagnosis and treatment of cancer. It is also a major centre for oncology clinical trials in Singapore, helping patients gain access to new and investigational treatments.

You may also be interested in: